A Phase II Clinical Trial of YH23537 in Patients With Chronic Periodontal Disease.

NCT02585596 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

275

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Periodontitis

Interventions

DRUG: YH23537 1000mg/day
DRUG: YH23537 2000mg/day
DRUG: YH23537 3000mg/day
DRUG: placebo

Sponsor

Yuhan Corporation